that the otosclerotic process was in some way directly responsible for the vestibular disturbances. Exactly how otosclerosis produces vestibular disturbances is not known, but from our knowledge of the histopathology of Meniere's disease and of otosclerosis, and by a careful analysis of the findings in the three cases recorded here, it is possible to make a few valid observations.
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Exactly how otosclerosis produces vestibular disturbances is not known, but from our knowledge of the histopathology of Meniere's disease and of otosclerosis, and by a careful analysis of the findings in the three cases recorded here, it is possible to make a few valid observations.
It is known that otosclerotic disease can and commonly does extend to involve the cochlea (Ruedi, 1962) and that this can produce a perceptive loss of hearing. It is also known that otosclerosis may involve the semicircular canals (Seligman and Shambaugh, 1951) , but the effect of this on vestibular function has not yet been assessed. Schuknecht et al. (1962) have compiled considerable histological evidence to show that the attacks of vertigo in Meniere's disease are due to rupture of the membranous labyrinth, causing a sudden admixture of the endolymph and perilymph. It has also been shown ) that labyrinthine otosclerosis can cause rupture of the basilar membrane through shrinkage of that part of the spiral ligament which lies adjacent to an otosclerotic focus.
It seems likely, therefore, that the explosive attacks of vertigo are due to sudden rupture of the membranous labyrinth, which has been rendered atrophic by its proximity to a focus of otosclerotic activity.
More difficult to explain is why the vertigo should cease after stapedectomy. Clearly, the only beneficial effect that this operation can confer upon the labyrinth is one of mechanical decompression.
By accommodating any alteration in the volume of the fluids, a mobile stapes footplate must help to prevent violent pressure changes within the labyrinth. If the footplate is fixed, *however, this compensatory adjustment no longer operates and the various membranous partitions are subjected to much greater and therefore more disruptive changes in pressure. A healthy endolymphatic labyrinth might be able to withstand these abnormal pressures, but if rendered " fragile " by adjacent otosclerotic disease then rupture could ensue. By restoring the normal " safety-valve " mechanism, stapedectomy mitigates the mechanical stresses imposed upon this delicate membranous labyrinth and thereby tends to prevent further episodes of vertigo.
As the three cases had bilateral otosclerosis, it would seem to have been a fortunate "fluke " that in each instance we operated on the ear that was causing the attacks of vertigo. In all three patients, however, there were indications which pointed to one ear as being responsible for the vestibular disturbance; loss of balance was accompanied by a temporary worsening of the deafness on one side in Case 1 and by an increase in the intensity of the unilateral tinnitus in Cases 2 and 3. In addition, stapedectomy was always carried out on the ear that showed the greater degree of deafness and was therefore presumed to be the more severely affected by otosclerosis.
Summary
Three cases of otosclerosis are described in which the patients suffered from recurrent severe episodes of vertigo similar to those of Meniere's disease. Labyrinthine otosclerosis induces atrophic changes in the membranous labyrinth, and it is postulated that vertigo is due to sudden rupture of the latter. In each patient the vertigo ceased after stapedectomy, and this was probably due to a decompression effect on the labyrinth. Brit. med. J., 1964, 2, 1229-1232 Immunological methods for the assay of growth hormone in human serum have been extensively studied since the introduction of an immunoassay by Read (1959) , using the haemagglutination technique. The original assay has proved unsatisfactory owing to interference from substances, probably protein in nature, present in serum (Grumbach and Kaplan, 1962) ; Dominguez and Pearson (1962) , however, have used the method after a preliminary extraction procedure. Immunoassays using radioiodine-labelled human growth hormone (H.G.H.) have been described by Hunter and Greenwood (1962a, 1964) , Utiger et al. (1962) , and Glick et al. (1963) ; we have used a technique very similar to that of Utiger et al.
In this paper our technique is described, together with the results obtained during glucose-tolerance tests and insulintolerance tests on acromegalic patients.
were obtained. After preliminary separation of the labelled hormone from iodide on a Sephadex G-50 column, as described by Hunter and Greenwood, the labelled hormone was passed through a Sephadex G-200 column, and the material emerging late in the second peak was used for the assay, since this has been reported to combine more completely with antiserum to H.G.H. (anti-H.G.H.) (Touber and Maingay, 1963 24 hours at 40 C. after the addition of anti-rabbit gamma-globulin. Initially the precipitated gamma-globulin was separated by filtration through Oxoid membrane filters, as described by Hales and Randle (1963) for the assay of insulin, but after considerable variability between batches of filters had been encountered separation was done by centrifugation. The tubes were centrifuged at 2,000 r.p.m. for 60 minutes at 4°C., decanted, the precipitates washed with buffer solution, and centrifuged again. The precipitates left in the tubes were counted in either a scintillation well-counter or in an automatic liquid scintillation counter.
Glucose-tolerance Tests
Glucose, 50 g., was given orally and venous blood taken at 0, 1, and 2 hours for blood sugar 
Results
The Assay A representative standard curve is shown in Fig. 1 In this and the other standard curves a straight line drawn by eye nearly fits the shape of the curve, and has been used for calculating the results of the assay. 
Results in Normal Subjects
With this assay, 14-hour fasting levels were measured in 22 normal adult subjects, of which all but two were below 10 1xmg./ml., the exceptions being 12 and 26 /Amg./ml. During glucose-tolerance tests the one-and two-hour levels were below 5 1umg./ml. in all the seven normal subjects studied. Seven subjects had insulin-tolerance tests using a standard dose of insulin (0. levels. Six patients were tested only after they had been treated by pituitary implantation; only one of these showed levels clearly in the acromegalic range. On the whole, the results agreed well with the other available clinical and test evidence of the activity of the disease. The augmented insulin-tolerance test has previously been found to be a satisfactory indirect test of the activity of acromegaly, patients with active acromegaly being insulin-resistant (Fraser et al., 1962) . samples of the glucose-tolerance test in treated and untreated acromegalic patients (r, 0.64 + 0.17). The patient whose insulin-resistance index increased after treatment, despite a fall in mean serum H.G.H. and clinical evidence of remission, had gained more than 1 stone (6.4 kg.) in weight ; this might explain that finding, since obesity has been shown to be associated with nearly as great an insulin resistance as acromegaly (Fraser et al., 1962) . Fig. 4 
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and have restricted the amount added to 0.1 ml. in a total volume of 0.7 ml. Control tubes of horse serum are included in each assay, and in the majority of assays we have not found any serious interference. These control tubes are used to define the upper limit of zero assays, although this assumes that the amount of non-specific interference produced by human serum is the same as that produced by horse serum. The absence of serious interference is also supported by the fact that numerous human sera have been assayed and not found to have detectable levels of H.G.H. The occurrence, however, of considerable degrees of interference in some assays suggests that we are just at the limit of the amount of serum which can be safely added to the system. Glick et al., 1963 ; Hunter and Greenwood, 1964) . However, isolated normal subjects have also been reported with high levels after an overnight fast; thus one subject reported by Roth et al. (1963a) had a value of 50 umg./ml., which is within the range found in the acromegalics. They also showed that serum H.G.H. levels in normal subjects are rapidly decreased after the administration of glucose, whereas one acromegalic patient described did not show this decrease. Therefore it seemed likely that assays during a glucose-tolerance test would provide a better assessment of the constant hypersecretion of acromegaly than would the measurement of levels after an overnight fast. All the untreated acromegalic patients not only showed high fasting levels of H.G.H. but these also remained high throughout the glucose-tolerance test. It is also interesting that three patients who were tested only after treatment showed levels which were little raised, but which did not fall after glucose, suggesting that their growth-hormone-secreting cells were still not responsive to normal stimuli. The augmented insulintolerance test, which is perhaps the best indirect test of the activity of acromegaly (Fraser et al., 1962) , has given results which correlate fairly well with the mean H.G.H. level during the glucose-tolerance test.
In normal subjects the serum H.G.H. level rises during hypoglycaemia (Roth et al., 1963b) , and we have therefore measured H.G.H. levels during insulin-tolerance tests on some acromegalic patients to see whether, during this test, they would show the same evidence of autonomy of growth-hormone secretion as was found during the glucose-tolerance tests. In view of their insulin resistance, they were given large doses of insulin (0.3 unit/kg.) to try to ensure considerable falls in blood sugar. In three of them there was virtually no change in serum H.G.H., while in the other two there was a pronounced rise. It would seem, from this evidence, that growth-hormone secretion can be increased by hypoglycaemia in some but not all acromegalic patients.
Summary
Immunoassays of serum growth hormone have been performed, using 13'I-labelled human growth hormone and a double precipitation method, which will measure values down to 1-2 ttmg./ml. In five active acromegalic patients the fasting levels were 24-74 [tmg./ml., and remained high throughout a glucose-tolerance test ; the mean serum level during a glucosetolerance test correlated well with other evidence of activity of the disease. After pituitary implantation the serum H.G.H. was usually lowered. During insulin-tolerance tests the serum growth hormone remained unchanged in three active acromegalic patients, but rose in two others.
